TG THERAPEUTICS IN earnings per share and revenue

NKB2 earnings per share for the last quarter are 0.02 CHF whereas the estimation was 0.03 CHF which accounts for -33.33% surprise. Company revenue for the same period amounts to 71.08 M CHF despite the estimated figure of 69.24 M CHF. Estimated earnings per share for the next quarter are 0.14 CHF, and revenue is expected to reach 99.28 M CHF. Also watch annual changes over time to get a bigger picture of NKB2 earnings per share and revenue dynamics.